CREDIT RISK UPDATES

Capillary Tech. sees a credit rating action

Capillary Tech.CAPILLARY

TL;DR

Company disclosures and reported filings do not state the initiation, terms of reference, or specific scope (business segments, geographies, or customer verticals) of a forensic audit for Capillary. Furthermore, granular segment-level, vertical, or geographic revenue and EBITDA margin breakdowns for the last two fiscal years are not separately reported.

Which specific business segments, geographies, or customer verticals are covered under the scope of the forensic audit, and have these areas historically contributed to the company's reported revenue growth or EBITDA margins in the last two fiscal years?

Scope of Forensic Audit and Historical Segment Contribution

Company disclosures and reported filings do not state the initiation, terms of reference, or specific scope (business segments, geographies, or customer verticals) of a forensic audit for Capillary. Furthermore, granular segment-level, vertical, or geographic revenue and EBITDA margin breakdowns for the last two fiscal years are not separately reported.

At the entity level, reported financials for FY26 establish the overall revenue and EBITDA baseline across standalone and consolidated operations.

---

Reported Financial Baseline (FY26 Summary)

While segment-wise and geographic contributions to growth and margin performance remain undisclosed, company-level reported metrics for FY26 provide the underlying financial framework:

  • Notes: Data reflects FY26 reported statements.*

---

Key Disclosure Gaps and Implications

  • Forensic Scope Unreported: Details regarding whether audit procedures focus on standalone operations, specific offshore subsidiaries, cross-border transactions, or specific customer contracts have not been disclosed.
  • Segment and Regional Visibility Gap: Because geographic (e.g., India, Middle East, Southeast Asia, US) and vertical revenue splits for FY25 and FY26 are omitted from disclosures, it is not possible to determine what portion of consolidated revenue (Rs 191.35 Crores [1]) or consolidated EBITDA (Rs 38.11 Crores [6]) originates from potentially audited business areas.
  • Entity Profitability Disparity: The margin variance between standalone EBITDA margin (33.4% [7]) and consolidated EBITDA margin (19.9% [8]) demonstrates lower operating profitability in subsidiary operations, making segment-level disclosures critical for assessing operational risk exposure.*
MetricStandalone (FY26)Consolidated (FY26)Operational Observation
RevenueRs 65.02 Crores [3]Rs 191.35 Crores [1]Consolidated top-line is ~2.9x standalone revenue, indicating substantial business volume outside the standalone parent entity
EBITDARs 21.73 Crores [5]Rs 38.11 Crores [6]Standalone unit contributes Rs 21.73 Crores to overall consolidated operating profit
EBITDA Margin33.4% [7]19.9% [8]Standalone entity reflects a significantly higher margin profile (+1,350 bps) than consolidated operations
PATRs 9.89 Crores [9]Rs 43.36 Crores [10]Consolidated PAT includes Rs 24.96 Crores in exceptional gain items [11]

What is the defined timeline for the completion of the forensic audit, and has the company committed to a specific disclosure schedule for the findings, particularly regarding potential restatements of historical financial statements?

I couldn't find relevant information for this query. Please try rephrasing or asking about a specific metric.

Sources

  1. [1]Revenue INR
  2. [2]Cash and Equivalents
  3. [3]Revenue INR
  4. [4]Cash and Equivalents
  5. [5]EBITDA
  6. [6]EBITDA
  7. [7]EBITDA Margin
  8. [8]EBITDA Margin
  9. [9]PAT
  10. [10]PAT
  11. [11]Exceptional Items

Keep digging

What is the specific quantum of the 'suspected fraudulent transactions' identified by the board, and how does this amount compare to the company's reported revenue and cash reserves in the most recent audited financial statements?

Ask Copilot
Logo

Unlock financial AI for your firm

Log in